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Current Opinion
Introduction
The last decade has been characterized by substantial changes
in the field of surgery for oesophageal motor disorders and
particularly for gastro-oesophageal reflux disease (GERD).
Major improvement, in fact, has been made in the under-
standing of the pathophysiology of the disease, in the ability to
diagnose it and in its surgical treatment. This is particularly
important today, as it is clear that GERD can progress to
Barrett’s oesophagus and eventually to adenocarcinoma.
Pathophysiology
During the 1980s the lower oesophageal sphincter (LES) was
considered the primary determinant of the antireflux barrier.
Initially, it was thought that reflux occurred because of a
“mechanical failure” of the LES.1 Zaninotto et al postulated
that reflux occurred when the LES resting pressure was less
than 6 mmHg, its total length less than 2 cm and the length of
the sphincter exposed to the positive intra-abdominal pressure,
less than 1 cm. However, this model failed to explain the cause
of reflux in about 40% of patients with GERD (confirmed by pH
monitoring).1 The explanation came from a landmark study by
Dodds and colleagues, who showed that the cause of reflux in
normal subjects, and in the majority of patients with GERD, is
actually secondary to a “functional failure” of the LES, due
to transient LES relaxation.2 Nonetheless, during the 1990s,
it became obvious that the pathogenesis of GERD is multi-
factorial. It was demonstrated that the striated muscles of the
oesophageal crus have a synergistic action with the smooth
muscle of the LES to protect the oesophagus against reflux,3
and that a hiatal hernia contributes to the incompetence of
the gastroesophageal junction by altering this anatomical
relationship. Specifically, it was shown that, in patients with
proven GERD, a large hiatal hernia impairs the function of
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the LES and prolongs oesophageal acid clearance, therefore,
producing more severe mucosal injury and increasing the risk
of pulmonary aspiration.4 While the role of the LES in the
pathogenesis of GERD has been studied extensively, in the
1980s, less attention was paid to the role of oesophageal
peristalsis, even though it was known that peristalsis governs
oesophageal acid clearance. Today, we know that 40% to 50% of
patients with GERD proven by pH monitoring have abnormal
peristalsis. This dysmotility is particularly severe in about 20%
of patients because of very low amplitude of peristalsis and/or
abnormal propagation of the peristaltic waves (ineffective
oesophageal motility [IEM]).5 In patients with IEM, more acid
refluxes and the oesophageal acid clearance is slower. As a
consequence, these patients have more severe mucosal injury
and more frequent respiratory symptoms.5 Overall, these studies
identified a subgroup of patients that has a more severe form of
disease characterized by abnormal motility and abnormal
oesophageal clearance, who frequently experience regurgitation
and respiratory symptoms in addition to heartburn. Earlier
surgical intervention in this group should be of benefit to
prevent the development of strictures or Barrett’s metaplasia
and to avoid severe lung damage.5, 6 Finally, it has been shown
that duodenal contents in addition to acid play a role in the
pathogenesis of GERD in about 60% of patients.7 This finding
is very important, as medical treatment only affects the acid
component of the gastric refluxate, while surgery re-establishes
the barrier provided by the LES against any type of reflux.
Clinical presentation
In addition to heartburn, regurgitation and dysphagia (typical
symptoms), patients may complain of chest pain, respiratory
symptoms (cough, wheezing, aspiration, choking), ear, nose
and throat manifestations (hoarseness, sore throat, otitis
media) or even dental problems (enamel erosion) (atypical
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symptoms).8 In most cases, atypical symptoms are due to
a pan-oesophageal motor disorder characterized by an
incompetent LES and poor peristalsis, which allow proximal
extension of the gastro-oesophageal reflux.9 Manometry and
pH monitoring are particularly important in patients with
atypical symptoms in order to diagnose GERD, establish a
correlation between symptoms and episodes of reflux and
predict the outcome of therapy.10
Diagnosis
Clinicians typically make the diagnosis of GERD from the
clinical findings and then prescribe acid-suppressing
drugs. Unfortunately this approach is wrong in 30% to 35% of
cases.11, 12 For example, among 822 patients with a clinical
diagnosis of GERD based on symptoms and endoscopic find-
ings, pH monitoring was abnormal in only 70% of cases.12 This
study confirmed that symptoms are unreliable in diagnosing
GERD, and that even endoscopic evidence of grade I-II oesopha-
gitis is diagnostically non-specific. In contrast, pH monitoring
identified patients with GERD and stratified them according
to the severity of the disease.12 More liberal use of oesophageal
manometry and pH monitoring early in patients’ management
might avoid much improper and costly medical therapy, and
would help single out for special attention the patients with
GERD who have the most severe disease. Therefore, the main
role of endoscopy is not to diagnose GERD (mucosal injury is
absent in about 50% of patients with GERD proven by pH
monitoring)12 but rather to diagnose the presence of Barrett’s
oesophagus and to rule out gastric and duodenal pathology.
Treatment
The advent of minimally invasive surgery has been the greatest
development of the last decade, and has changed the treatment
algorithm of many diseases such as achalasia and GERD.
Today, a laparoscopic fundoplication provides the same
excellent results as open surgery (resolution of symptoms in
more than 90% of patients), but it is associated with a 1- or
2- day hospital stay, minimal postoperative discomfort and fast
return to regular activity.13,14
Indications for surgery
The indications for surgery have also changed during the last
10 years. In the past, fundoplication was indicated in patients
who did not improve when treated with antacids or histamine
blocking agents. Today, the pendulum has shifted 180˚ and
the best candidate for surgery is considered a patient who has
complete resolution of symptoms when treated with proton
pump inhibitors.15 A “non responder” requires a thorough
work-up to elucidate the cause of the foregut symptoms, and
an alternative diagnosis, ranging from irritable bowel syndrome
to gallbladder disease, is frequently found.12
Patients who have regurgitation and respiratory symptoms
or hoarseness are also ideal candidates for fundoplication.
Even complete elimination of gastric acid secretion by proton
pump inhibitors frequently fails to control these symptoms.
This is because it only alters the pH of the gastric refluxate but
does not prevent the regurgitation and upward extent of
reflux, which are often due to an incompetent LES and impaired
oesophageal peristalsis.9,10,16 Analysis of pH tracings to look
for a correlation between symptoms and episodes of reflux
helps in predicting the outcome of surgery.10 Young patients
might also choose an operation early in the course of their
disease in order to avoid a life long commitment to lifestyle
changes and medications.
Many surgeons also consider the presence of Barrett’s
oesophagus as an indication for surgical rather than medical
treatment, based on the following considerations: 1) proton
pump inhibitors, although effective in controlling the acid
component of the refluxate, do not eliminate the reflux of bile
which is a major contributor to the pathogenesis of Barrett’s
epithelium. 2) Patients with Barrett’s oesophagus have lower
LES pressure and defective peristalsis more often than do
those without Barrett’s esophagus.17 As a consequence, their
mucosa is exposed to larger amounts of gastric refluxate.
3) There is evidence that suggests that an effective antireflux
operation can prevent progression from metaplasia to
dysplasia.18 In a prospective randomized trial of medical versus
surgical therapy for patients with Barrett’s oesophagus (meta-
plasia), Ortiz and colleagues showed that progression from
metaplasia to dysplasia occurred in 22% of subjects treated
medically, but in only 3% of patients treated surgically.18
Nonetheless, the definitive answer awaits the results of further
randomized controlled studies. We presently recommend
endoscopic surveillance after laparoscopic fundoplication.
Surgical technique
The improved understanding of the pathogenesis of GERD
and the development of minimally invasive techniques during
the past decade have not been accompanied by a consensus on
what constitutes an optimal antireflux operation. Surgeons
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still refer to operations described decades ago, such as the
Nissen, the Toupet, the Guarner and the Hill procedures. The
problem with this approach is that none of these operations,
as originally described, constitutes the ideal operation for
GERD. Nonetheless, each contains important technical
elements of genuine importance for the creation of an effective
antireflux barrier. Today’s goal is to focus on these elements
and forget the eponyms.
• Dissection of the oesophagus in the posterior mediastinum:
this manoeuvre allows 3 to 4 cm of the oesophagus to lie
without tension below the diaphragm.
• Division of the short gastric vessels: both the anterior and
posterior gastric walls can be used for the creation of a
floppy fundoplication.
• Closure of the oesophageal hiatus: avoids herniation of the
wrap and strengthens the LES. Failure of the crural closure
and malformation of the wrap have been identified as the
most common causes of failure in the laparoscopic era.19
• Type of wrap: today a 360˚ fundoplication is considered
the procedure of choice. The wrap should be constructed
over a 56- to 60-French bougie. In the past, in an attempt
to decrease the incidence of postoperative dysphagia, we
tailored the type of wrap (360˚ versus 240˚) based on the
quality of oesophageal peristalsis, and chose a partial
fundoplication when severe dysmotility was present.13
However, long-term follow-up of our patients and the
results from other centres have shown that a partial
fundoplication is not as effective as a total fundoplication
and that dysmotility does not require tailoring of
the operation.20,21 A partial fundoplication should be used
only in patients with connective tissue disorders and
primary oesophageal motility disorders such as achalasia.
• Fixation of the wrap to the oesophagus and to the dia-
phragm: prevents herniation of the wrap in the posterior
mediastinum and lateral rotation.13
Conclusions
The goal of antireflux surgery is to control reflux without crea-
ting troublesome side effects. Today, this goal can be achieved
in the majority of patients by a thorough preoperative evalu-
ation and an operation that includes the elements listed above.
References
1. Zaninotto G, DeMeester TR, Schwitzer W, et al. The lower oesophageal
sphincter in health and disease. Am J Surg 1988;155:104–11.
2. Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal
reflux in patients with reflux esophagitis. N Engl J Med 1982;307:
1547–52.
3. Mittal RK, Rochester DF, McCallum RW. Sphincteric action of the
diaphragm during a relaxed lower oesophageal sphincter in humans.
Am J Physiol 1989;256:139–44.
4. Patti MG, Goldberg HI, Arcerito M, et al. Hiatal hernia size affects
the lower oesophageal sphincter function, oesophageal acid exposure,
and the degree of mucosal injury. Am J Surg 1996;171:182–6.
5. Diener U, Patti MG, Molena D, et al. Oesophageal dysmotility and
gastroesophageal reflux disease. J Gastrointest Surg 2001;5:260–5.
6. Monnier P, Ollyo JP, Fontoilliet C, Savary M. Epidemiology and
natural history of reflux esophagitis. Semin Laparosc Surg 1995;2:2–9.
7. Kauer WKH, Peters JH, DeMeester TR, et al. Mixed reflux of gastric
and duodenal juices is more harmful to the oesophagus than gastric
juice alone. The need for surgical therapy re-emphasized. Ann Surg
1995;222:525–33.
8. Richter JE. Typical and atypical presentation of gastroesophageal
reflux disease. The role of oesophageal testing in diagnosis and
management. Gastroenterol Clin N Am 1996;25:75–102.
9. Patti MG, Debas HT, Pellegrini CA. Clinical and functional characteri-
zation of high gastroesophageal reflux. Am J Surg 1993;165:163–8.
10. Patti MG, Arcerito M, Tamburini A, et al. Effect of laparoscopic
fundoplication on gastroesophageal reflux disease-induced
respiratory symptoms. J Gastrointest Surg 2000;4;143–9.
11. Costantini M, Crookes PF, Bremner RM, et al. Value of physiologic
assessment of foregut symptoms in a surgical practice. Surgery 1993;
114:780–7.
12. Patti MG, Diener U, Molena D, Way LW. Role of oesophageal
function tests in diagnosis of gastroesophageal reflux disease. Dig
Dis Sci 2001;46:597–602.
13. Patti MG, Arcerito M, Feo CV, et al. An analysis of operations for
gastroesophageal reflux disease. Identifying the important technical
elements. Arch Surg 1998;133:601–7.
14. Peters JH, DeMeester TR, Crookes P, et al. The treatment of
gastroesophageal reflux disease with laparoscopic Nissen
fundoplication. Ann Surg 1998;228:40–50.
15. Campos GM, Peters JH, DeMeester TR, et al. Multivariate analysis of
factors predicting outcome after laparoscopic Nissen fundoplication.
J Gastrointest Surg 1999;3:292–300.
16. Wetscher GJ, Glaser K, Hinder RA, et al. Respiratory symptoms in
patients with gastroesophageal reflux disease following medical
therapy and following antireflux surgery. Am J Surg 1997;174:
639–43.
17. Patti MG, Arcerito M, Feo CV, et al. Barrett’s oesophagus: a surgical
disease. J Gastrointest Surg 1999;3:397–403.
18. Ortiz A, Martinez de Haro LF, Parilla P, et al. Conservative treatment
versus antireflux surgery in Barrett’s oesophagus: long-term results
of a prospective study. Br J Surg 1996;83:274–8.
19. Horgan S, Pohl D, Bogetti D, et al. Failed antireflux surgery. What
have we learned from reoperations? Arch Surg 1999;134:809–17.
20. Horvath KD, Jobe BA, Herron DM, Swanstrom LL. Laparoscopic
Toupet fundoplication is an inadequate procedure for patients with
severe oesophageal reflux disease. J Gastrointest Surg 1999;3:583–7.
21. Heading RC. Should abnormal oesophageal motility in gastro-
oesophageal reflux disease influence decisions about fundoplication?
Gut 2002;50:592–3.
